Skip to main content
. 2024 Jan 2;24:13. doi: 10.1186/s12885-023-11719-z

Table 2.

Analysis of correlation factors with RFS

Factors Univariate analysis Multivariate analysis
All patients(n = 254) HR 95% CI P Value HR 95% CI P Value
Age at diagnosis
 ≤ 50 1 1
 > 50 2.097 1.254–3.507 0.005 1.891 1.098–3.257 0.022
Clinical stage
 II 1 1
 III 2.171 1.256–3.751 0.005 1.597 0.875–2.913 0.127
Pathologic T stage after NAC  < 0.001 0.023
 ypT0 1 1
 ypT1 1.157 0.623–2.148 0.645 0.592 0.288–1.216 0.154
 ypT2 1.432 0.724–2.832 0.302 0.542 0.240–1.221 0.139
 ypT3 10.484 2.445–44.957 0.002 2.023 0.389–10.512 0.402
 ypT4 10.677 3.161–36.058  < 0.001 3.837 0.996–14.777 0.051
Pathologic N stage after NAC  < 0.001 0.167
 ypN0 1 1
 ypN1 2.084 1.015–4.278 0.045 1.354 0.565–3.247 0.497
 ypN2 4.431 2.218–8.850  < 0.001 1.933 0.811–4.604 0.137
 ypN3 7.267 3.213–16.439  < 0.001 2.895 1.064–7.873 0.037
LVI
 Negative 1 1
 Positive 2.755 1.566–4.847  < 0.001 1.384 0.748–2.562 0.300
RCB system  < 0.001 0.003
 0 1 1
 I 0.581 0.117–2.880 0.506 0.712 0.141–3.591 0.680
 II 2.601 1.054–6.418 0.038 3.270 1.228–8.707 0.018
 III 4.946 2.051–11.926  < 0.001 5.108 1.838–14.199 0.002

Abbreviations: LVI Lymphatic vessel invasion